nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentosan Polysulfate—FGF1—neck—esophageal cancer	0.0249	0.14	CbGeAlD
Pentosan Polysulfate—FGF2—bronchus—esophageal cancer	0.0225	0.126	CbGeAlD
Pentosan Polysulfate—FGF2—smooth muscle tissue—esophageal cancer	0.022	0.123	CbGeAlD
Pentosan Polysulfate—FGF2—trachea—esophageal cancer	0.0202	0.113	CbGeAlD
Pentosan Polysulfate—FGF1—epithelium—esophageal cancer	0.017	0.0951	CbGeAlD
Pentosan Polysulfate—FGF1—smooth muscle tissue—esophageal cancer	0.0163	0.0917	CbGeAlD
Pentosan Polysulfate—FGF2—lung—esophageal cancer	0.0145	0.0813	CbGeAlD
Pentosan Polysulfate—FGF1—digestive system—esophageal cancer	0.0129	0.0724	CbGeAlD
Pentosan Polysulfate—FGF1—lung—esophageal cancer	0.0108	0.0604	CbGeAlD
Pentosan Polysulfate—FGF2—lymph node—esophageal cancer	0.00991	0.0556	CbGeAlD
Pentosan Polysulfate—FGF1—lymph node—esophageal cancer	0.00737	0.0413	CbGeAlD
Pentosan Polysulfate—Prothrombin level increased—Capecitabine—esophageal cancer	0.00546	0.0354	CcSEcCtD
Pentosan Polysulfate—Optic neuritis—Cisplatin—esophageal cancer	0.00494	0.032	CcSEcCtD
Pentosan Polysulfate—Infection—Carboplatin—esophageal cancer	0.00367	0.0238	CcSEcCtD
Pentosan Polysulfate—Raised liver function tests—Methotrexate—esophageal cancer	0.00361	0.0234	CcSEcCtD
Pentosan Polysulfate—Appetite absent—Methotrexate—esophageal cancer	0.00335	0.0217	CcSEcCtD
Pentosan Polysulfate—Rectal haemorrhage—Capecitabine—esophageal cancer	0.00248	0.0161	CcSEcCtD
Pentosan Polysulfate—Lacrimation increased—Capecitabine—esophageal cancer	0.00243	0.0157	CcSEcCtD
Pentosan Polysulfate—Colitis—Capecitabine—esophageal cancer	0.00215	0.0139	CcSEcCtD
Pentosan Polysulfate—Dehydration—Cisplatin—esophageal cancer	0.00205	0.0133	CcSEcCtD
Pentosan Polysulfate—Oesophagitis—Capecitabine—esophageal cancer	0.00205	0.0133	CcSEcCtD
Pentosan Polysulfate—Mouth ulceration—Capecitabine—esophageal cancer	0.00203	0.0131	CcSEcCtD
Pentosan Polysulfate—Ecchymosis—Capecitabine—esophageal cancer	0.00203	0.0131	CcSEcCtD
Pentosan Polysulfate—Sweating increased—Cisplatin—esophageal cancer	0.00186	0.012	CcSEcCtD
Pentosan Polysulfate—Photosensitivity—Capecitabine—esophageal cancer	0.00185	0.012	CcSEcCtD
Pentosan Polysulfate—Abdominal discomfort—Cisplatin—esophageal cancer	0.00183	0.0118	CcSEcCtD
Pentosan Polysulfate—Vaginal inflammation—Methotrexate—esophageal cancer	0.00167	0.0108	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Cisplatin—esophageal cancer	0.00166	0.0107	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Cisplatin—esophageal cancer	0.00165	0.0107	CcSEcCtD
Pentosan Polysulfate—Vaginal infection—Methotrexate—esophageal cancer	0.00158	0.0102	CcSEcCtD
Pentosan Polysulfate—Mood swings—Capecitabine—esophageal cancer	0.00154	0.00998	CcSEcCtD
Pentosan Polysulfate—Dehydration—Capecitabine—esophageal cancer	0.00151	0.0098	CcSEcCtD
Pentosan Polysulfate—Ecchymosis—Methotrexate—esophageal cancer	0.00151	0.00977	CcSEcCtD
Pentosan Polysulfate—Mouth ulceration—Methotrexate—esophageal cancer	0.00151	0.00977	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Capecitabine—esophageal cancer	0.0015	0.00973	CcSEcCtD
Pentosan Polysulfate—Gastritis—Capecitabine—esophageal cancer	0.00144	0.00932	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Cisplatin—esophageal cancer	0.00142	0.00922	CcSEcCtD
Pentosan Polysulfate—Photosensitivity—Methotrexate—esophageal cancer	0.00138	0.00893	CcSEcCtD
Pentosan Polysulfate—Angina pectoris—Capecitabine—esophageal cancer	0.00137	0.00887	CcSEcCtD
Pentosan Polysulfate—Sweating increased—Capecitabine—esophageal cancer	0.00137	0.00887	CcSEcCtD
Pentosan Polysulfate—Alopecia—Cisplatin—esophageal cancer	0.00135	0.00874	CcSEcCtD
Pentosan Polysulfate—Abdominal discomfort—Capecitabine—esophageal cancer	0.00135	0.00873	CcSEcCtD
Pentosan Polysulfate—Flatulence—Cisplatin—esophageal cancer	0.00131	0.00848	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Capecitabine—esophageal cancer	0.00128	0.00831	CcSEcCtD
Pentosan Polysulfate—Weight increased—Capecitabine—esophageal cancer	0.00128	0.00829	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Capecitabine—esophageal cancer	0.00127	0.00824	CcSEcCtD
Pentosan Polysulfate—Depression—Capecitabine—esophageal cancer	0.00125	0.0081	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Cisplatin—esophageal cancer	0.00123	0.00799	CcSEcCtD
Pentosan Polysulfate—Anaemia—Cisplatin—esophageal cancer	0.00123	0.00796	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Capecitabine—esophageal cancer	0.00122	0.00791	CcSEcCtD
Pentosan Polysulfate—Jaundice—Capecitabine—esophageal cancer	0.00122	0.00791	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Capecitabine—esophageal cancer	0.00122	0.00789	CcSEcCtD
Pentosan Polysulfate—Malaise—Cisplatin—esophageal cancer	0.0012	0.00776	CcSEcCtD
Pentosan Polysulfate—Haematuria—Capecitabine—esophageal cancer	0.0012	0.00774	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Cisplatin—esophageal cancer	0.00119	0.0077	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Capecitabine—esophageal cancer	0.00118	0.00766	CcSEcCtD
Pentosan Polysulfate—Mood swings—Methotrexate—esophageal cancer	0.00115	0.00743	CcSEcCtD
Pentosan Polysulfate—Myalgia—Cisplatin—esophageal cancer	0.00113	0.00733	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Capecitabine—esophageal cancer	0.00113	0.00731	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Methotrexate—esophageal cancer	0.00112	0.00724	CcSEcCtD
Pentosan Polysulfate—Discomfort—Cisplatin—esophageal cancer	0.00112	0.00724	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Capecitabine—esophageal cancer	0.00112	0.00723	CcSEcCtD
Pentosan Polysulfate—Oedema—Cisplatin—esophageal cancer	0.00108	0.00702	CcSEcCtD
Pentosan Polysulfate—Infection—Cisplatin—esophageal cancer	0.00108	0.00698	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Cisplatin—esophageal cancer	0.00106	0.00688	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Capecitabine—esophageal cancer	0.00105	0.0068	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Cisplatin—esophageal cancer	0.00105	0.00679	CcSEcCtD
Pentosan Polysulfate—Anorexia—Cisplatin—esophageal cancer	0.00103	0.0067	CcSEcCtD
Pentosan Polysulfate—Abdominal discomfort—Methotrexate—esophageal cancer	0.001	0.0065	CcSEcCtD
Pentosan Polysulfate—Alopecia—Capecitabine—esophageal cancer	0.000995	0.00644	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000988	0.0064	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Cisplatin—esophageal cancer	0.000974	0.00631	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Cisplatin—esophageal cancer	0.000967	0.00626	CcSEcCtD
Pentosan Polysulfate—Flatulence—Capecitabine—esophageal cancer	0.000966	0.00625	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000956	0.00619	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Cisplatin—esophageal cancer	0.000943	0.00611	CcSEcCtD
Pentosan Polysulfate—Depression—Methotrexate—esophageal cancer	0.000931	0.00603	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Methotrexate—esophageal cancer	0.00091	0.00589	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Capecitabine—esophageal cancer	0.000909	0.00589	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Methotrexate—esophageal cancer	0.000907	0.00587	CcSEcCtD
Pentosan Polysulfate—Anaemia—Capecitabine—esophageal cancer	0.000906	0.00586	CcSEcCtD
Pentosan Polysulfate—Sweating—Methotrexate—esophageal cancer	0.000895	0.00579	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Cisplatin—esophageal cancer	0.000894	0.00579	CcSEcCtD
Pentosan Polysulfate—Haematuria—Methotrexate—esophageal cancer	0.00089	0.00576	CcSEcCtD
Pentosan Polysulfate—Malaise—Capecitabine—esophageal cancer	0.000884	0.00572	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Methotrexate—esophageal cancer	0.00088	0.0057	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Capecitabine—esophageal cancer	0.000877	0.00568	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Capecitabine—esophageal cancer	0.000834	0.0054	CcSEcCtD
Pentosan Polysulfate—Myalgia—Capecitabine—esophageal cancer	0.000834	0.0054	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Methotrexate—esophageal cancer	0.000832	0.00538	CcSEcCtD
Pentosan Polysulfate—Discomfort—Capecitabine—esophageal cancer	0.000824	0.00534	CcSEcCtD
Pentosan Polysulfate—Oedema—Capecitabine—esophageal cancer	0.0008	0.00518	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Cisplatin—esophageal cancer	0.000799	0.00518	CcSEcCtD
Pentosan Polysulfate—Infection—Capecitabine—esophageal cancer	0.000794	0.00514	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Capecitabine—esophageal cancer	0.000783	0.00507	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Methotrexate—esophageal cancer	0.000781	0.00506	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Capecitabine—esophageal cancer	0.000773	0.00501	CcSEcCtD
Pentosan Polysulfate—Anorexia—Capecitabine—esophageal cancer	0.000762	0.00494	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Cisplatin—esophageal cancer	0.000742	0.00481	CcSEcCtD
Pentosan Polysulfate—Alopecia—Methotrexate—esophageal cancer	0.00074	0.00479	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000729	0.00472	CcSEcCtD
Pentosan Polysulfate—Insomnia—Capecitabine—esophageal cancer	0.000723	0.00468	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Capecitabine—esophageal cancer	0.000718	0.00465	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Capecitabine—esophageal cancer	0.000713	0.00462	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Capecitabine—esophageal cancer	0.000704	0.00456	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Capecitabine—esophageal cancer	0.000695	0.0045	CcSEcCtD
Pentosan Polysulfate—Vomiting—Cisplatin—esophageal cancer	0.00069	0.00447	CcSEcCtD
Pentosan Polysulfate—Rash—Cisplatin—esophageal cancer	0.000684	0.00443	CcSEcCtD
Pentosan Polysulfate—Constipation—Capecitabine—esophageal cancer	0.000684	0.00443	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Cisplatin—esophageal cancer	0.000683	0.00442	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Methotrexate—esophageal cancer	0.000677	0.00438	CcSEcCtD
Pentosan Polysulfate—Anaemia—Methotrexate—esophageal cancer	0.000674	0.00437	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Capecitabine—esophageal cancer	0.000659	0.00427	CcSEcCtD
Pentosan Polysulfate—Malaise—Methotrexate—esophageal cancer	0.000658	0.00426	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000654	0.00423	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Methotrexate—esophageal cancer	0.000653	0.00423	CcSEcCtD
Pentosan Polysulfate—Nausea—Cisplatin—esophageal cancer	0.000644	0.00417	CcSEcCtD
Pentosan Polysulfate—Urticaria—Capecitabine—esophageal cancer	0.000635	0.00411	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Capecitabine—esophageal cancer	0.000632	0.00409	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Methotrexate—esophageal cancer	0.000621	0.00402	CcSEcCtD
Pentosan Polysulfate—Myalgia—Methotrexate—esophageal cancer	0.000621	0.00402	CcSEcCtD
Pentosan Polysulfate—Discomfort—Methotrexate—esophageal cancer	0.000614	0.00397	CcSEcCtD
Pentosan Polysulfate—Infection—Methotrexate—esophageal cancer	0.000591	0.00383	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Capecitabine—esophageal cancer	0.000589	0.00381	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Methotrexate—esophageal cancer	0.000583	0.00377	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Methotrexate—esophageal cancer	0.000575	0.00373	CcSEcCtD
Pentosan Polysulfate—Anorexia—Methotrexate—esophageal cancer	0.000567	0.00367	CcSEcCtD
Pentosan Polysulfate—Pruritus—Capecitabine—esophageal cancer	0.000566	0.00366	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Capecitabine—esophageal cancer	0.000547	0.00354	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000542	0.00351	CcSEcCtD
Pentosan Polysulfate—Insomnia—Methotrexate—esophageal cancer	0.000538	0.00349	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Methotrexate—esophageal cancer	0.000535	0.00346	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Methotrexate—esophageal cancer	0.000531	0.00344	CcSEcCtD
Pentosan Polysulfate—Dizziness—Capecitabine—esophageal cancer	0.000529	0.00342	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Methotrexate—esophageal cancer	0.000524	0.00339	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Methotrexate—esophageal cancer	0.000517	0.00335	CcSEcCtD
Pentosan Polysulfate—Vomiting—Capecitabine—esophageal cancer	0.000508	0.00329	CcSEcCtD
Pentosan Polysulfate—Rash—Capecitabine—esophageal cancer	0.000504	0.00326	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Capecitabine—esophageal cancer	0.000504	0.00326	CcSEcCtD
Pentosan Polysulfate—Headache—Capecitabine—esophageal cancer	0.000501	0.00324	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Methotrexate—esophageal cancer	0.000491	0.00318	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000487	0.00315	CcSEcCtD
Pentosan Polysulfate—Nausea—Capecitabine—esophageal cancer	0.000475	0.00308	CcSEcCtD
Pentosan Polysulfate—Urticaria—Methotrexate—esophageal cancer	0.000473	0.00306	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Methotrexate—esophageal cancer	0.000471	0.00305	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Methotrexate—esophageal cancer	0.000439	0.00284	CcSEcCtD
Pentosan Polysulfate—Pruritus—Methotrexate—esophageal cancer	0.000421	0.00273	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Methotrexate—esophageal cancer	0.000407	0.00264	CcSEcCtD
Pentosan Polysulfate—Dizziness—Methotrexate—esophageal cancer	0.000394	0.00255	CcSEcCtD
Pentosan Polysulfate—Vomiting—Methotrexate—esophageal cancer	0.000378	0.00245	CcSEcCtD
Pentosan Polysulfate—Rash—Methotrexate—esophageal cancer	0.000375	0.00243	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Methotrexate—esophageal cancer	0.000375	0.00243	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by ERBB2—PIK3CA—esophageal cancer	0.000374	0.00056	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PFN1—esophageal cancer	0.000374	0.00056	CbGpPWpGaD
Pentosan Polysulfate—FGF2—B Cell Activation—EGFR—esophageal cancer	0.000373	0.000559	CbGpPWpGaD
Pentosan Polysulfate—Headache—Methotrexate—esophageal cancer	0.000373	0.00241	CcSEcCtD
Pentosan Polysulfate—FGF2—DAP12 signaling—PIK3CA—esophageal cancer	0.000372	0.000558	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—CDKN1A—esophageal cancer	0.000372	0.000557	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PSME1—esophageal cancer	0.00037	0.000554	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PSME2—esophageal cancer	0.00037	0.000554	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—ANXA1—esophageal cancer	0.000368	0.000552	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—PIK3CA—esophageal cancer	0.000367	0.00055	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CSNK1A1—esophageal cancer	0.000364	0.000546	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PSME2—esophageal cancer	0.000363	0.000544	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PSME1—esophageal cancer	0.000363	0.000544	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—ACTB—esophageal cancer	0.000363	0.000544	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	0.000361	0.000541	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—HSPA5—esophageal cancer	0.00036	0.000539	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—SST—esophageal cancer	0.000358	0.000537	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—KDR—esophageal cancer	0.000358	0.000536	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—EGFR—esophageal cancer	0.000357	0.000535	CbGpPWpGaD
Pentosan Polysulfate—FGF1—B Cell Activation—PIK3CA—esophageal cancer	0.000355	0.000532	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—B2M—esophageal cancer	0.000355	0.000532	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PTPN2—esophageal cancer	0.000355	0.000531	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Methotrexate—esophageal cancer	0.000354	0.00229	CcSEcCtD
Pentosan Polysulfate—FGF2—Immune System—B2M—esophageal cancer	0.000351	0.000525	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—MET—esophageal cancer	0.00035	0.000525	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR in disease—PIK3CA—esophageal cancer	0.00035	0.000525	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 interactions—PIK3CA—esophageal cancer	0.00035	0.000525	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Fc epsilon receptor (FCERI) signaling—PIK3CA—esophageal cancer	0.00035	0.000525	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	0.00035	0.000524	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—NOTCH3—esophageal cancer	0.000349	0.000523	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—GHRL—esophageal cancer	0.000349	0.000523	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CALR—esophageal cancer	0.000349	0.000522	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—XIAP—esophageal cancer	0.000348	0.000522	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR—PIK3CA—esophageal cancer	0.000347	0.00052	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—TLR4—esophageal cancer	0.000347	0.00052	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR in Cancer—PIK3CA—esophageal cancer	0.000344	0.000515	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—FBXW7—esophageal cancer	0.000343	0.000515	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by PDGF—PIK3CA—esophageal cancer	0.000342	0.000513	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PFN1—esophageal cancer	0.000341	0.00051	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—ENO1—esophageal cancer	0.00034	0.00051	CbGpPWpGaD
Pentosan Polysulfate—FGF1—NGF signalling via TRKA from the plasma membrane—PIK3CA—esophageal cancer	0.00034	0.00051	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—CDKN1A—esophageal cancer	0.000339	0.000508	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—NOTCH1—esophageal cancer	0.000337	0.000505	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—FBXW7—esophageal cancer	0.000337	0.000505	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ELMO1—esophageal cancer	0.000336	0.000503	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PSME2—esophageal cancer	0.000335	0.000502	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PSME1—esophageal cancer	0.000335	0.000502	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—CDKN1A—esophageal cancer	0.000334	0.0005	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PSME1—esophageal cancer	0.000331	0.000496	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PSME2—esophageal cancer	0.000331	0.000496	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	0.000329	0.000494	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—HSPA5—esophageal cancer	0.000328	0.000492	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—AKAP13—esophageal cancer	0.000328	0.000491	CbGpPWpGaD
Pentosan Polysulfate—FGF2—B Cell Activation—PIK3CA—esophageal cancer	0.000324	0.000486	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—B2M—esophageal cancer	0.000324	0.000485	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—HMGB1—esophageal cancer	0.000322	0.000483	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CALR—esophageal cancer	0.000322	0.000482	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—CDKN1A—esophageal cancer	0.000321	0.000481	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	0.000319	0.000478	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—TLR4—esophageal cancer	0.000318	0.000477	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CALR—esophageal cancer	0.000318	0.000476	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—EP300—esophageal cancer	0.000318	0.000476	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—TLR4—esophageal cancer	0.000316	0.000474	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—NOTCH2—esophageal cancer	0.000313	0.000469	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—FBXW7—esophageal cancer	0.000311	0.000466	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—ENO1—esophageal cancer	0.00031	0.000465	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—PIK3CA—esophageal cancer	0.00031	0.000465	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—FBXW7—esophageal cancer	0.000307	0.000461	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—HIF1A—esophageal cancer	0.000307	0.00046	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ELMO1—esophageal cancer	0.000306	0.000459	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PSME2—esophageal cancer	0.000306	0.000458	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PSME1—esophageal cancer	0.000306	0.000458	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—CREBBP—esophageal cancer	0.000306	0.000458	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000303	0.000454	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—EGFR—esophageal cancer	0.000301	0.000452	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PDE4D—esophageal cancer	0.0003	0.000449	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—AKAP13—esophageal cancer	0.000299	0.000448	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—CASP8—esophageal cancer	0.000297	0.000446	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—CREBBP—esophageal cancer	0.000296	0.000444	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—HMGB1—esophageal cancer	0.000294	0.00044	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CALR—esophageal cancer	0.000293	0.00044	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—GNG7—esophageal cancer	0.000285	0.000428	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—FBXW7—esophageal cancer	0.000284	0.000425	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—NOS2—esophageal cancer	0.000279	0.000419	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TGFBR2—esophageal cancer	0.000278	0.000416	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—NOTCH1—esophageal cancer	0.000277	0.000415	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000276	0.000414	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—EGFR—esophageal cancer	0.000275	0.000412	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PDE4D—esophageal cancer	0.000274	0.00041	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—CASP8—esophageal cancer	0.000273	0.000409	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—CREBBP—esophageal cancer	0.000272	0.000407	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—CASP8—esophageal cancer	0.000271	0.000406	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—EGFR—esophageal cancer	0.000271	0.000406	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—CREBBP—esophageal cancer	0.00027	0.000405	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—XIAP—esophageal cancer	0.000267	0.000401	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—ABL1—esophageal cancer	0.000266	0.000399	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—SMAD4—esophageal cancer	0.000263	0.000394	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—PIK3CA—esophageal cancer	0.000262	0.000392	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—GNG7—esophageal cancer	0.00026	0.00039	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—EGFR—esophageal cancer	0.00026	0.00039	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—ERBB2—esophageal cancer	0.000256	0.000384	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—BCL2—esophageal cancer	0.000255	0.000383	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CTNNA1—esophageal cancer	0.000253	0.000379	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—TGFBR2—esophageal cancer	0.000252	0.000377	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CXCL2—esophageal cancer	0.000251	0.000377	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—CREBBP—esophageal cancer	0.000251	0.000376	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—ERBB2—esophageal cancer	0.000248	0.000372	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—XIAP—esophageal cancer	0.000244	0.000365	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—ABL1—esophageal cancer	0.000243	0.000364	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—PIK3CA—esophageal cancer	0.000239	0.000357	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—SMAD4—esophageal cancer	0.000238	0.000357	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—ERBB2—esophageal cancer	0.000238	0.000357	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—PIK3CA—esophageal cancer	0.000235	0.000352	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PSME2—esophageal cancer	0.000235	0.000352	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PSME1—esophageal cancer	0.000235	0.000352	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—BCL2—esophageal cancer	0.000234	0.000351	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ANXA1—esophageal cancer	0.000234	0.00035	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—BCL2—esophageal cancer	0.000233	0.000349	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CTNNA1—esophageal cancer	0.000231	0.000345	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—TGFBR2—esophageal cancer	0.00023	0.000344	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CXCL2—esophageal cancer	0.000229	0.000343	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—ERBB2—esophageal cancer	0.000228	0.000341	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—SST—esophageal cancer	0.000227	0.000341	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—ERBB2—esophageal cancer	0.000226	0.000339	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—PIK3CA—esophageal cancer	0.000226	0.000338	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—NOS3—esophageal cancer	0.000225	0.000337	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—GHRL—esophageal cancer	0.000222	0.000332	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NOTCH3—esophageal cancer	0.000222	0.000332	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—FBXW7—esophageal cancer	0.000218	0.000327	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—SMAD4—esophageal cancer	0.000217	0.000326	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—ERBB2—esophageal cancer	0.000217	0.000325	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—HIF1A—esophageal cancer	0.000215	0.000322	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PSME2—esophageal cancer	0.000214	0.000321	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PSME1—esophageal cancer	0.000214	0.000321	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ANXA1—esophageal cancer	0.000213	0.000319	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—CDKN1A—esophageal cancer	0.000212	0.000318	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—ERBB2—esophageal cancer	0.00021	0.000315	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—EP300—esophageal cancer	0.000208	0.000312	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—SST—esophageal cancer	0.000207	0.000311	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—KDR—esophageal cancer	0.000206	0.000308	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—PTGS2—esophageal cancer	0.000205	0.000308	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—CDKN1A—esophageal cancer	0.000204	0.000305	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NOTCH3—esophageal cancer	0.000202	0.000303	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—GHRL—esophageal cancer	0.000202	0.000303	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—TLR4—esophageal cancer	0.000202	0.000303	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—EP300—esophageal cancer	0.000202	0.000302	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—FBXW7—esophageal cancer	0.000199	0.000298	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NOTCH2—esophageal cancer	0.000199	0.000298	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—HIF1A—esophageal cancer	0.000195	0.000292	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—CDKN1A—esophageal cancer	0.000194	0.000291	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—NOTCH1—esophageal cancer	0.000194	0.00029	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—CDKN1A—esophageal cancer	0.000193	0.00029	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—CDKN1A—esophageal cancer	0.000186	0.000278	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—EP300—esophageal cancer	0.000185	0.000277	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—TLR4—esophageal cancer	0.000184	0.000276	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—EP300—esophageal cancer	0.000184	0.000276	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NOTCH2—esophageal cancer	0.000181	0.000272	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—CDKN1A—esophageal cancer	0.00018	0.000269	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—HIF1A—esophageal cancer	0.000178	0.000266	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—EGFR—esophageal cancer	0.000177	0.000266	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—NOS2—esophageal cancer	0.000177	0.000266	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TGFBR2—esophageal cancer	0.000176	0.000264	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CREBBP—esophageal cancer	0.000176	0.000263	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—NOTCH1—esophageal cancer	0.000176	0.000263	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CASP8—esophageal cancer	0.000173	0.00026	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CREBBP—esophageal cancer	0.000172	0.000258	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—EGFR—esophageal cancer	0.000172	0.000258	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—EP300—esophageal cancer	0.000171	0.000256	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—SMAD4—esophageal cancer	0.000167	0.00025	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—EGFR—esophageal cancer	0.000165	0.000247	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—NOS2—esophageal cancer	0.000162	0.000242	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TGFBR2—esophageal cancer	0.000161	0.000241	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—NOTCH1—esophageal cancer	0.00016	0.00024	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CREBBP—esophageal cancer	0.000159	0.000239	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CASP8—esophageal cancer	0.000158	0.000237	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—EGFR—esophageal cancer	0.000158	0.000236	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—NOS3—esophageal cancer	0.000157	0.000236	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CREBBP—esophageal cancer	0.000157	0.000236	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—EGFR—esophageal cancer	0.000157	0.000235	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—SMAD4—esophageal cancer	0.000152	0.000228	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—EGFR—esophageal cancer	0.000151	0.000226	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—PIK3CA—esophageal cancer	0.000149	0.000224	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—MYC—esophageal cancer	0.000149	0.000223	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—BCL2—esophageal cancer	0.000149	0.000223	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—ERBB2—esophageal cancer	0.000147	0.00022	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—EGFR—esophageal cancer	0.000146	0.000218	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CREBBP—esophageal cancer	0.000145	0.000218	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—ERBB2—esophageal cancer	0.000144	0.000216	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—PIK3CA—esophageal cancer	0.000143	0.000215	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—NOS3—esophageal cancer	0.000143	0.000214	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—PIK3CA—esophageal cancer	0.000137	0.000205	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—HIF1A—esophageal cancer	0.000137	0.000205	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—PIK3CA—esophageal cancer	0.000136	0.000204	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—BCL2—esophageal cancer	0.000136	0.000203	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—ERBB2—esophageal cancer	0.000133	0.0002	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—ERBB2—esophageal cancer	0.000132	0.000197	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—PIK3CA—esophageal cancer	0.000131	0.000196	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KDR—esophageal cancer	0.000131	0.000196	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PTGS2—esophageal cancer	0.00013	0.000195	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—NOS3—esophageal cancer	0.00013	0.000195	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CCND1—esophageal cancer	0.00013	0.000195	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—PIK3CA—esophageal cancer	0.000126	0.000189	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CDKN1A—esophageal cancer	0.000126	0.000188	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HIF1A—esophageal cancer	0.000124	0.000187	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CDKN1A—esophageal cancer	0.000123	0.000185	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NOTCH1—esophageal cancer	0.000123	0.000184	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—ERBB2—esophageal cancer	0.000122	0.000182	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—EP300—esophageal cancer	0.00012	0.000179	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KDR—esophageal cancer	0.000119	0.000178	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PTGS2—esophageal cancer	0.000119	0.000178	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—EP300—esophageal cancer	0.000117	0.000176	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CDKN1A—esophageal cancer	0.000114	0.000171	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CDKN1A—esophageal cancer	0.000113	0.000169	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NOTCH1—esophageal cancer	0.000112	0.000168	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CREBBP—esophageal cancer	0.000112	0.000167	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—EP300—esophageal cancer	0.000108	0.000163	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—EP300—esophageal cancer	0.000107	0.000161	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MYC—esophageal cancer	0.000104	0.000156	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CDKN1A—esophageal cancer	0.000104	0.000156	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—EGFR—esophageal cancer	0.000102	0.000153	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CREBBP—esophageal cancer	0.000102	0.000152	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—EGFR—esophageal cancer	0.0001	0.00015	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NOS3—esophageal cancer	9.98e-05	0.00015	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—EP300—esophageal cancer	9.89e-05	0.000148	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MYC—esophageal cancer	9.45e-05	0.000142	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ERBB2—esophageal cancer	9.34e-05	0.00014	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—EGFR—esophageal cancer	9.24e-05	0.000139	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—EGFR—esophageal cancer	9.13e-05	0.000137	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NOS3—esophageal cancer	9.1e-05	0.000136	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PIK3CA—esophageal cancer	8.85e-05	0.000133	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PIK3CA—esophageal cancer	8.69e-05	0.00013	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MYC—esophageal cancer	8.62e-05	0.000129	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TP53—esophageal cancer	8.56e-05	0.000128	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ERBB2—esophageal cancer	8.52e-05	0.000128	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—EGFR—esophageal cancer	8.43e-05	0.000126	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CCND1—esophageal cancer	8.25e-05	0.000124	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PIK3CA—esophageal cancer	8.02e-05	0.00012	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CDKN1A—esophageal cancer	7.98e-05	0.00012	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PIK3CA—esophageal cancer	7.92e-05	0.000119	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—EP300—esophageal cancer	7.59e-05	0.000114	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CCND1—esophageal cancer	7.52e-05	0.000113	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PIK3CA—esophageal cancer	7.32e-05	0.00011	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CDKN1A—esophageal cancer	7.28e-05	0.000109	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—EP300—esophageal cancer	6.93e-05	0.000104	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MYC—esophageal cancer	6.62e-05	9.92e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—EGFR—esophageal cancer	6.47e-05	9.7e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MYC—esophageal cancer	6.04e-05	9.04e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—EGFR—esophageal cancer	5.9e-05	8.85e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3CA—esophageal cancer	5.62e-05	8.42e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TP53—esophageal cancer	5.43e-05	8.14e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3CA—esophageal cancer	5.12e-05	7.68e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TP53—esophageal cancer	4.96e-05	7.43e-05	CbGpPWpGaD
